We’re pleased to announce that Biocytogen will be attending SfN Neuroscience 2025, taking place November 15–19 in San Diego, CA! Join us for a dynamic program featuring keynote lectures, scientific sessions, rapid abstract presentations, and hands-on workshops exploring a broad spectrum of neuroscience topics.Take part in poster sessions, discover cutting-edge innovations at the exhibit hall, and connect through valuable networking opportunities and discussions on the future of brain science. Be sure to visit Booth #436 to meet the Biocytogen team and learn how we’re advancing the future of biotechnology. We hope to see you there!
What is SFN?
Neuroscience 2025, hosted by the Society for Neuroscience, features a comprehensive program including keynote lectures, scientific sessions, rapid abstract presentations, and hands-on workshops covering the full spectrum of brain research. Attendees can engage in poster sessions, learn about different exhibitors and their studies on life sciences and participate in professional development and networking events fit for all career stages. The conference fosters scientific exchange, collaboration, and exposure to the latest innovations in neuroscience.
Event Overview
Date: November 15th-19th, 2025
Venue: San Diego Convention Center. 111 Harbor Dr, San Diego, CA
Event Schedule
For more information, please refer to SFN Schedule
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We can’t wait to see you in San Diego, CA!
